Bumetanide oral solution for the treatment of children and adolescents with autism spectrum disorder: Results from two randomized phase III studies.

Fuentes J, Parellada M, Georgoula C, Oliveira G, Marret S, Crutel V, Albarran C, Lambert E, Pénélaud PF, Ravel D, Ben Ari Y

Open source

DOI: 10.1002/aur.3005
Published: 2023 Oct
Container: Autism research : official journal of the International Society for Autism Research
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/aur.3005,
  title = {Bumetanide oral solution for the treatment of children and adolescents with autism spectrum disorder: Results from two randomized phase III studies.},
  author = {Fuentes J and Parellada M and Georgoula C and Oliveira G and Marret S and Crutel V and Albarran C and Lambert E and Pénélaud PF and Ravel D and Ben Ari Y},
  year = {2023},
  journal = {Autism research : official journal of the International Society for Autism Research},
  doi = {10.1002/aur.3005},
  url = {https://doi.org/10.1002/aur.3005}
}

RIS

TY  - JOUR
TI  - Bumetanide oral solution for the treatment of children and adolescents with autism spectrum disorder: Results from two randomized phase III studies.
AU  - Fuentes J
AU  - Parellada M
AU  - Georgoula C
AU  - Oliveira G
AU  - Marret S
AU  - Crutel V
AU  - Albarran C
AU  - Lambert E
AU  - Pénélaud PF
AU  - Ravel D
AU  - Ben Ari Y
PY  - 2023
JO  - Autism research : official journal of the International Society for Autism Research
DO  - 10.1002/aur.3005
UR  - https://doi.org/10.1002/aur.3005
ER  -

APA

J, F., M, P., C, G., G, O., S, M., V, C., C, A., E, L., PF, P., D, R., & Y, B. A. (2023). Bumetanide oral solution for the treatment of children and adolescents with autism spectrum disorder: Results from two randomized phase III studies.. Autism research : official journal of the International Society for Autism Research. https://doi.org/10.1002/aur.3005

Source records

pubmed · retrieved 2026-09-26T04:34:25.258Z
europe-pmc · retrieved 2026-09-26T04:34:25.269Z